93 related articles for article (PubMed ID: 3698017)
21. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
22. Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.
Livingston PO; Calves MJ; Natoli EJ
J Immunol; 1987 Mar; 138(5):1524-9. PubMed ID: 3805726
[TBL] [Abstract][Full Text] [Related]
23. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response.
Richie JP; McDonald J; Gittes RF
Surgery; 1981 Aug; 90(2):214-20. PubMed ID: 7256537
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin.
Fidler IJ; Gruys E; Cifone MA; Barnes Z; Bucana C
J Natl Cancer Inst; 1981 Oct; 67(4):947-56. PubMed ID: 6944560
[TBL] [Abstract][Full Text] [Related]
25. Primary malignant melanoma of the oral cavity. Case report and establishment of melanoma cell line.
Tagawa T; Yatani R; Nishioka H; Murata M
Int J Oral Surg; 1981; 10(Suppl 1):16-20. PubMed ID: 6807872
[TBL] [Abstract][Full Text] [Related]
26. Melanoma growth and tumorigenicity in models of microgravity.
Taga M; Yamauchi K; Odle J; Furian L; Sundaresan A; Ramesh GT; Pellis NR; Andrassy RJ; Kulkarni AD
Aviat Space Environ Med; 2006 Nov; 77(11):1113-6. PubMed ID: 17086762
[TBL] [Abstract][Full Text] [Related]
27. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
28. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN
J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
[TBL] [Abstract][Full Text] [Related]
29. Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells.
Kameyama K; Vieira WD; Tsukamoto K; Law LW; Hearing VJ
Int J Cancer; 1990 Jun; 45(6):1151-8. PubMed ID: 2161802
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
31. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
32. The establishment and characterization of a cell line and mouse xenografts from a human malignant melanoma.
McCormick D; Wallace I; Kirk J; Dinsmore S; Allen I
Br J Exp Pathol; 1983 Feb; 64(1):103-15. PubMed ID: 6838761
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenicity of the mixed spindle-epithelioid SP6.5 and epithelioid TP17 uveal melanoma cell lines is differentially related to alpha5beta1 integrin expression.
Béliveau A; Bérubé M; Carrier P; Mercier C; Guérin SL
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3058-65. PubMed ID: 11687555
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line.
Imai M; Muraki M; Takamatsu K; Saito H; Seiki M; Takahashi Y
BMC Cancer; 2008 Nov; 8():319. PubMed ID: 18980698
[TBL] [Abstract][Full Text] [Related]
35. In vivo reexpression of H-2 antigens in B16 melanoma cells.
Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
[TBL] [Abstract][Full Text] [Related]
36. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
37. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8.
Singh RK; Gutman M; Reich R; Bar-Eli M
Cancer Res; 1995 Aug; 55(16):3669-74. PubMed ID: 7543020
[TBL] [Abstract][Full Text] [Related]
38. JB/MS murine melanoma: a new model for studies on the modulation of differentiation and of tumorigenic and metastatic potential.
Hearing VJ; Cannon GB; Vieira WD; Jiménez-Atiénzar M; Kameyama K; Law LW
Int J Cancer; 1988 Feb; 41(2):275-82. PubMed ID: 2828247
[TBL] [Abstract][Full Text] [Related]
39. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
40. A unique tumor rejection antigen from the S91 murine malignant melanoma.
Law LW; Vieira WD; Kameyama K; Hearing VJ
Cancer Res; 1987 Nov; 47(22):5841-5. PubMed ID: 3664485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
